Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TISAGENLECLEUCEL Cause Activated partial thromboplastin time prolonged? 20 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Activated partial thromboplastin time prolonged have been filed in association with TISAGENLECLEUCEL (KYMRIAH). This represents 0.5% of all adverse event reports for TISAGENLECLEUCEL.

20
Reports of Activated partial thromboplastin time prolonged with TISAGENLECLEUCEL
0.5%
of all TISAGENLECLEUCEL reports
4
Deaths
15
Hospitalizations

How Dangerous Is Activated partial thromboplastin time prolonged From TISAGENLECLEUCEL?

Of the 20 reports, 4 (20.0%) resulted in death, 15 (75.0%) required hospitalization, and 9 (45.0%) were considered life-threatening.

Is Activated partial thromboplastin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TISAGENLECLEUCEL. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does TISAGENLECLEUCEL Cause?

Cytokine release syndrome (1,660) Pyrexia (1,030) Malignant neoplasm progression (582) Hypotension (425) Immune effector cell-associated neurotoxicity syndrome (416) Neurotoxicity (411) Platelet count decreased (397) White blood cell count decreased (392) Hypogammaglobulinaemia (374) Lymphocyte count decreased (365)

What Other Drugs Cause Activated partial thromboplastin time prolonged?

DABIGATRAN ETEXILATE (264) HEPARIN (225) RIVAROXABAN (163) WARFARIN (146) ACETAMINOPHEN (119) ALLOPURINOL (110) AMIODARONE (99) METRONIDAZOLE (98) SIMVASTATIN (94) DARBEPOETIN ALFA (93)

Which TISAGENLECLEUCEL Alternatives Have Lower Activated partial thromboplastin time prolonged Risk?

TISAGENLECLEUCEL vs TISLELIZUMAB TISAGENLECLEUCEL vs TISOTUMAB VEDOTIN TISAGENLECLEUCEL vs TISOTUMAB VEDOTIN-TFTV TISAGENLECLEUCEL vs TITANIUM DIOXIDE\ZINC TISAGENLECLEUCEL vs TIVICAY

Related Pages

TISAGENLECLEUCEL Full Profile All Activated partial thromboplastin time prolonged Reports All Drugs Causing Activated partial thromboplastin time prolonged TISAGENLECLEUCEL Demographics